Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA) for people aged 65 and up
Official title: Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An RCT and a Qualitative Evaluation of a Psychosocial Intervention for Suicidal Adults Aged 65+
Run by Vastra Gotaland Region · NCT06831942 · Data updated 2026-11-12
This randomized study will test whether a version of the ASSIP counseling program adapted for people aged 65 and older reduces repeat suicide attempts and ongoing suicidal thoughts compared with usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 132 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 2 sites (Borås and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | June 2029 |
| Study ends | June 2031 |
| Registry record updated | November 18, 2025 |
| Trial ID | NCT06831942 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are Swedish-speaking adults aged 65 or older who recently attempted suicide or were hospitalized for serious suicidal plans and are able to give informed consent and engage in outpatient psychosocial treatment.
✕Probably not a fit
People with dementia or very low cognitive scores, ongoing delirium, severe psychosis, severe active substance use disorder, conditions requiring longer specialized treatments (e.g., DBT), terminal illness, or insufficient Swedish language ability are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will run a randomized controlled trial in Sweden comparing ASSIP-OA, a version of the Attempted Suicide Short Intervention Program adapted for adults 65 and older, to treatment as usual. Participants who recently attempted suicide or were hospitalized for serious suicidal plans and who can provide informed consent will receive ASSIP-OA plus standard mental health follow-up or usual care. The trial will track outcomes such as new suicide attempts and suicidal ideation over follow-up to see if the adapted program produces similar reductions to those seen in prior ASSIP studies. Study sites include Södra Älvsborg Hospital in Borås and Sahlgrenska University Hospital in Gothenburg.
Why it matters
Potential benefit: If successful, ASSIP-OA could substantially lower the risk of repeat suicide attempts and suicidal thoughts among older adults, improving safety and quality of life.
How similar studies have gone: The original ASSIP developed in Switzerland showed about an 80% reduction in new suicide attempts compared with ordinary treatment in prior studies, but ASSIP has not been widely tested specifically in older adults in Europe.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 65 and above at time of index suicide attempt or hospitalisation for serious suicidal plans. 2. A mental health care contact during the active treatment period. 3. Capable of understanding study procedures and providing informed consent. Exclusion Criteria: 1. Clinical diagnosis of dementia or MoCa score less than -2 standard deviations from the normative score for education and age (Borland et al., 2017). Ongoing delirium, or any other condition impeding the comprehension of the study's procedures and implications that hinder the provision of informed consent. 2. Severe ongoing psychosis, severe ongoing substance use disorder, emotionally instable personality syndrome and any other condition that would require longer specialized treatment to reduce future suicidal behaviour (e.g. DBT). 3. Terminal illness. 4. Insufficient knowledge of the Swedish language (requires interpreter). 5. Aphasia or other severe communication issue or severe hearing and/or severe visual impairment that render the intervention unfeasible despite corrective aids.
Where it's running
-
Södra Älvsborg Hospital
Borås, Sweden Recruiting -
Sahlgrenska University Hospital
Gothenburg, Sweden Not yet recruiting
Study contacts
- Principal investigator: Margda Waern, Professor — Department of Psychiatry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
- Study coordinator: Sara Hed, Phd Student
- Email: sara.hed@gu.se
- Phone: +46735324985
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Culturally adapted suicide prevention for Black middle school students in Chicago
This pilot will try a culturally adapted Signs of Suicide program to see if it helps Black middle school students in Chicago recognize suicidal thoughts and get help.
-
Inhaled DMT for major depressive disorder
This trial tests whether inhaled DMT can quickly ease depressive symptoms and reduce suicide risk in adults with major depressive disorder.
-
Remote case management to prevent suicide after psychiatric hospital discharge
This project will test whether a 6-month remote program called Pathfinding helps active-duty Army soldiers reduce suicidal behavior after leaving inpatient psychiatric care.
-
Text reminders to help parents keep teens safe after a suicide-related ED visit
This study tests whether sending parents text messages can help them reduce their teen’s access to lethal means and increase safety practices after a suicide-related emergency visit.
-
Co-creating suicide prevention tools for people in prison
This project will work with people in prison and prison care staff to test and adapt three suicide prevention tools so they fit prison life and are easier to use.
-
Crisis Response Planning added to intensive Cognitive Processing Therapy to reduce suicide risk in PTSD
We will test whether adding Crisis Response Planning to intensive Cognitive Processing Therapy helps reduce suicidal thoughts and behaviors in military members and veterans with PTSD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.